163 related articles for article (PubMed ID: 20020587)
1. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
Guran T; Turan S; Bircan R; Bereket A
J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diagnosis of thyroid hormone resistance.
Asteria C; Rajanayagam O; Collingwood TN; Persani L; Romoli R; Mannavola D; Zamperini P; Buzi F; Ciralli F; Chatterjee VK; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
[TBL] [Abstract][Full Text] [Related]
3. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P
Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
[TBL] [Abstract][Full Text] [Related]
4. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
Anzai R; Adachi M; Sho N; Muroya K; Asakura Y; Onigata K
Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347
[TBL] [Abstract][Full Text] [Related]
5. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
[TBL] [Abstract][Full Text] [Related]
6. Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered.
Mannavola D; Vannucchi G; Fugazzola L; Cerutti N; Persani L; Beck-Peccoz P
J Endocrinol Invest; 2002 Feb; 25(2):RC4-6. PubMed ID: 11929097
[TBL] [Abstract][Full Text] [Related]
7. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
Mechelany C; Schlumberger M; Challeton C; Comoy E; Parmentier C
Clin Endocrinol (Oxf); 1991 Aug; 35(2):123-8. PubMed ID: 1934526
[TBL] [Abstract][Full Text] [Related]
8. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
Darendeliler F; Baş F
J Pediatr Endocrinol Metab; 1997; 10(5):535-8. PubMed ID: 9401912
[No Abstract] [Full Text] [Related]
9. Pituitary resistance to thyroid hormone caused by a novel mutation (H435A) in the thyroid hormone receptor beta: A case report.
Yu C; Zhao J; Yao J; Wang H; Shang H; Zhang R; Cui Y; Wang L; Dong J; Liao L
Medicine (Baltimore); 2018 May; 97(21):e10544. PubMed ID: 29794730
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
Dulgeroff AJ; Geffner ME; Koyal SN; Wong M; Hershman JM
J Clin Endocrinol Metab; 1992 Oct; 75(4):1071-5. PubMed ID: 1400873
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.
Bracco D; Morin O; Schutz Y; Liang H; Jéquier E; Burger AG
J Clin Endocrinol Metab; 1993 Jul; 77(1):221-8. PubMed ID: 8325946
[TBL] [Abstract][Full Text] [Related]
12. A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up.
Hamon B; Hamon P; Bovier-Lapierre M; Pugeat M; Savagner F; Rodien P; Orgiazzi J
Thyroid; 2008 Jan; 18(1):35-44. PubMed ID: 18302516
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting effects of Triac and thyroxine on the control of thyrotropin and hepatic deiodinase type I.
Juge-Aubry CE; Morin O; Pernin AT; Liang H; Philippe J; Burger AG
Eur J Endocrinol; 1995 Jun; 132(6):751-8. PubMed ID: 7788017
[TBL] [Abstract][Full Text] [Related]
14. Association between an R338L mutation in the thyroid hormone receptor-beta gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone.
Menzaghi C; Balsamo A; Di Paola R; Gallone G; Rossi C; Tassi V; Fonzo D; De Filippis V
Thyroid; 1999 Jan; 9(1):1-6. PubMed ID: 10037068
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy.
Pohlenz J; Knöbl D
Acta Paediatr; 1996 Mar; 85(3):387-90. PubMed ID: 8696005
[TBL] [Abstract][Full Text] [Related]
16. [Hyperthyroidism caused by inadequate TSH secretion].
Zass R; Steindor U; Wendel U
Monatsschr Kinderheilkd; 1993 Feb; 141(2):100-2. PubMed ID: 7681522
[TBL] [Abstract][Full Text] [Related]
17. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
[TBL] [Abstract][Full Text] [Related]
18. 3,5,3'-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma.
Mueller-Gaertner HW; Schneider C
Clin Endocrinol (Oxf); 1988 Apr; 28(4):345-51. PubMed ID: 3142712
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.
Torre P; Bertoli M; Di Giovanni S; Scommegna S; Conte C; Novelli G; Cianfarani S
J Endocrinol Invest; 2005; 28(7):657-62. PubMed ID: 16218051
[TBL] [Abstract][Full Text] [Related]
20. [Resistance to thyroid hormones].
Jiskra J; Límanová Z
Cas Lek Cesk; 2014; 153(3):137-41. PubMed ID: 24968291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
